# EDGAR Filing Document

**Accession Number:** 0000904333
**File Stem:** 0001410368-25-010391
**Filing Date:** 2025-9
**Character Count:** 108921
**Document Hash:** 1f358ac3fe1dcd51a9a24246e6e059f0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-25-010391.hdr.sgml**: 20250924

**ACCESSION NUMBER**: 0001410368-25-010391

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250924

**DATE AS OF CHANGE**: 20250924

**PERIOD START**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SCHWAB CAPITAL TRUST
- **CENTRAL INDEX KEY:** 0000904333

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07704
- **FILM NUMBER:** 251339157

**BUSINESS ADDRESS:**
- **STREET 1:** 211 MAIN STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** 1-415-667-7000

**MAIL ADDRESS:**
- **STREET 1:** 211 MAIN STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

## Series and Classes Contracts Data

### Schwab Health Care Fund (Series ID: S000005519)

| Class ID   | Class Name              | Ticker Symbol   |
|:---|:---|:---|
| C000015021 | Schwab Health Care Fund | SWHFX           |

## Nport-Ex

Schwab Capital Trust

Schwab Core Equity Fund

------

**Portfolio Holdings** as of July 31, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 100.1% OF NET ASSETS | **COMMON STOCKS** 100.1% OF NET ASSETS | **COMMON STOCKS** 100.1% OF NET ASSETS |
| **Capital Goods 5.3%** | **Capital Goods 5.3%** | **Capital Goods 5.3%** |
| A.O. Smith Corp.  | 189437 | 13410245 |
| Caterpillar, Inc.  | 52565 | 23024521 |
| CNH Industrial NV  | 670153 | 8685183 |
| Fastenal Co.  | 158636 | 7317879 |
| Parker-Hannifin Corp.  | 12337 | 9029450 |
| Rockwell Automation, Inc.  | 49912 | 17554550 |
|  |  | **79021828** |
| **Commercial & Professional Services 2.2%** | **Commercial & Professional Services 2.2%** | **Commercial & Professional Services 2.2%** |
| Republic Services, Inc., Class A  | 80544 | 18577473 |
| Rollins, Inc.  | 238162 | 13639538 |
|  |  | **32217011** |
| **Consumer Discretionary Distribution & Retail 5.4%** | **Consumer Discretionary Distribution & Retail 5.4%** | **Consumer Discretionary Distribution & Retail 5.4%** |
| Amazon.com, Inc. \* | 239000 | 55952290 |
| TJX Cos., Inc.  | 198528 | 24722692 |
|  |  | **80674982** |
| **Consumer Staples Distribution & Retail 1.4%** | **Consumer Staples Distribution & Retail 1.4%** | **Consumer Staples Distribution & Retail 1.4%** |
| Walmart, Inc.  | 218272 | **21386291** |
| **Energy 4.2%** | **Energy 4.2%** | **Energy 4.2%** |
| EOG Resources, Inc.  | 161844 | 19424517 |
| Exxon Mobil Corp.  | 377413 | 42134387 |
|  |  | **61558904** |
| **Equity Real Estate Investment Trusts (REITs) 0.5%** | **Equity Real Estate Investment Trusts (REITs) 0.5%** | **Equity Real Estate Investment Trusts (REITs) 0.5%** |
| Public Storage  | 26907 | **7317090** |
| **Financial Services 11.1%** | **Financial Services 11.1%** | **Financial Services 11.1%** |
| Blackrock, Inc.  | 11812 | 13064190 |
| CME Group, Inc.  | 41495 | 11547229 |
| &nbsp;&nbsp;&nbsp;&nbsp; Fidelity National Information Services, <br> Inc. <br>| 630979 | 50106042 |
| Morgan Stanley  | 81764 | 11648099 |
| PayPal Holdings, Inc. \* | 563877 | 38772183 |
| Visa, Inc., Class A  | 114272 | 39477548 |
|  |  | **164615291** |
| **Food, Beverage & Tobacco 1.2%** | **Food, Beverage & Tobacco 1.2%** | **Food, Beverage & Tobacco 1.2%** |
| Constellation Brands, Inc., Class A  | 109687 | **18322116** |
| **Health Care Equipment & Services 6.2%** | **Health Care Equipment & Services 6.2%** | **Health Care Equipment & Services 6.2%** |
| Becton Dickinson & Co.  | 104044 | 18545843 |
| Boston Scientific Corp. \* | 185329 | 19444719 |
| Dexcom, Inc. \* | 197154 | 15924128 |
| Intuitive Surgical, Inc. \* | 28025 | 13482547 |
| UnitedHealth Group, Inc.  | 96346 | 24044108 |
|  |  | **91441345** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Household & Personal Products 2.1%** | **Household & Personal Products 2.1%** | **Household & Personal Products 2.1%** |
| L'Oreal SA, Sponsored ADR *(a)* | 141090 | 12490698 |
| Procter & Gamble Co.  | 120494 | 18130732 |
|  |  | **30621430** |
| **Insurance 3.2%** | **Insurance 3.2%** | **Insurance 3.2%** |
| Marsh & McLennan Cos., Inc.  | 34710 | 6914232 |
| Old Republic International Corp.  | 372146 | 13460521 |
| Progressive Corp.  | 111528 | 26994237 |
|  |  | **47368990** |
| **Materials 1.2%** | **Materials 1.2%** | **Materials 1.2%** |
| Linde PLC  | 38378 | **17663858** |
| **Media & Entertainment 10.2%** | **Media & Entertainment 10.2%** | **Media & Entertainment 10.2%** |
| Alphabet, Inc., Class A  | 397231 | 76228629 |
| Meta Platforms, Inc., Class A  | 96988 | 75014399 |
|  |  | **151243028** |
| **Pharmaceuticals, Biotechnology & Life Sciences 6.2%** | **Pharmaceuticals, Biotechnology & Life Sciences 6.2%** | **Pharmaceuticals, Biotechnology & Life Sciences 6.2%** |
| Eli Lilly & Co.  | 42701 | 31601729 |
| Johnson & Johnson  | 80652 | 13286611 |
| Thermo Fisher Scientific, Inc.  | 79702 | 37275031 |
| Zoetis, Inc.  | 61886 | 9022360 |
|  |  | **91185731** |
| **Semiconductors & Semiconductor Equipment 14.8%** | **Semiconductors & Semiconductor Equipment 14.8%** | **Semiconductors & Semiconductor Equipment 14.8%** |
| ASML Holding NV, Registry Shares  | 20750 | 14415232 |
| Broadcom, Inc.  | 204158 | 59961205 |
| NVIDIA Corp.  | 813380 | 144675901 |
|  |  | **219052338** |
| **Software & Services 16.0%** | **Software & Services 16.0%** | **Software & Services 16.0%** |
| Accenture PLC, Class A  | 37155 | 9924101 |
| Gartner, Inc. \* | 17008 | 5759759 |
| International Business Machines Corp.  | 80986 | 20501606 |
| Microsoft Corp.  | 292866 | 156244011 |
| Palo Alto Networks, Inc. \* | 78684 | 13659542 |
| Salesforce, Inc.  | 117073 | 30243468 |
|  |  | **236332487** |
| **Technology Hardware & Equipment 6.1%** | **Technology Hardware & Equipment 6.1%** | **Technology Hardware & Equipment 6.1%** |
| Apple, Inc.  | 387826 | 80501043 |
| Motorola Solutions, Inc.  | 21898 | 9612784 |
|  |  | **90113827** |

---

**1**

------

Schwab Core Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Utilities 2.8%** | **Utilities 2.8%** | **Utilities 2.8%** |
| NextEra Energy, Inc.  | 213529 | 15173371 |
| WEC Energy Group, Inc.  | 235695 | 25709610 |
|  |  | **40882981** |
| **Total Common Stocks**<br> **(Cost $804,528,634)** | **Total Common Stocks**<br> **(Cost $804,528,634)** | **1481019528** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **SHORT-TERM INVESTMENTS** 0.8% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.8% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.8% OF NET ASSETS |
| **Money Market Funds 0.8%** | **Money Market Funds 0.8%** | **Money Market Funds 0.8%** |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional <br> U.S. Government Money Market <br> Fund, Premier Class 4.25% *(b)*<br>| 762484 | 762484 |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional <br> U.S. Government Money Market <br> Fund, Premier Class 4.25% *(b)(c)*<br>| 10592250 | 10592250 |
|  |  | **11354734** |
| **Total Short-Term Investments**<br> **(Cost $11,354,734)** | **Total Short-Term Investments**<br> **(Cost $11,354,734)** | **11354734** |
| **Total Investments in Securities**<br> **(Cost $815,883,368)** | **Total Investments in Securities**<br> **(Cost $815,883,368)** | **1492374262** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

*(a)* All or a portion of this security is on loan. Securities on loan were valued at $10,251,774. 

*(b)* The rate shown is the annualized 7-day yield.

*(c)* Security purchased with cash collateral received for securities on loan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

ADR — American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of July 31, 2025 (see notes to portfolio holdings for additional information):

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $1481019528 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $1481019528 |
| Short-Term Investments<sup>1</sup> <br>| 11354734 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 11354734 |
| **Total** | **$1492374262** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$1492374262** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**2**

------

Schwab Capital Trust

Schwab Dividend Equity Fund

------

**Portfolio Holdings** as of July 31, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 98.3% OF NET ASSETS | **COMMON STOCKS** 98.3% OF NET ASSETS | **COMMON STOCKS** 98.3% OF NET ASSETS |
| **Banks 8.1%** | **Banks 8.1%** | **Banks 8.1%** |
| Bank of America Corp.  | 250000 | 11817500 |
| JPMorgan Chase & Co.  | 100000 | 29624000 |
| Truist Financial Corp.  | 90000 | 3933900 |
|  |  | **45375400** |
| **Capital Goods 10.2%** | **Capital Goods 10.2%** | **Capital Goods 10.2%** |
| Caterpillar, Inc.  | 10000 | 4380200 |
| CNH Industrial NV  | 200000 | 2592000 |
| Fastenal Co.  | 124000 | 5720120 |
| General Dynamics Corp.  | 15000 | 4674150 |
| Illinois Tool Works, Inc.  | 18500 | 4735445 |
| Lockheed Martin Corp.  | 27000 | 11366460 |
| Parker-Hannifin Corp.  | 13000 | 9514700 |
| Rockwell Automation, Inc.  | 9750 | 3429172 |
| RTX Corp.  | 43000 | 6775510 |
| Watsco, Inc.  | 8000 | 3607040 |
|  |  | **56794797** |
| **Consumer Discretionary Distribution & Retail 4.9%** | **Consumer Discretionary Distribution & Retail 4.9%** | **Consumer Discretionary Distribution & Retail 4.9%** |
| Genuine Parts Co.  | 35000 | 4510800 |
| Home Depot, Inc.  | 30150 | 11080427 |
| TJX Cos., Inc.  | 95000 | 11830350 |
|  |  | **27421577** |
| **Consumer Services 2.1%** | **Consumer Services 2.1%** | **Consumer Services 2.1%** |
| McDonald's Corp.  | 39000 | **11702730** |
| **Consumer Staples Distribution & Retail 3.2%** | **Consumer Staples Distribution & Retail 3.2%** | **Consumer Staples Distribution & Retail 3.2%** |
| Walmart, Inc.  | 185000 | **18126300** |
| **Energy 7.5%** | **Energy 7.5%** | **Energy 7.5%** |
| Chevron Corp.  | 100000 | 15164000 |
| Exxon Mobil Corp.  | 165000 | 18420600 |
| Kinder Morgan, Inc.  | 290000 | 8137400 |
|  |  | **41722000** |
| **Equity Real Estate Investment Trusts (REITs) 2.1%** | **Equity Real Estate Investment Trusts (REITs) 2.1%** | **Equity Real Estate Investment Trusts (REITs) 2.1%** |
| Lamar Advertising Co., Class A  | 40000 | 4890000 |
| Public Storage  | 25000 | 6798500 |
|  |  | **11688500** |
| **Financial Services 10.5%** | **Financial Services 10.5%** | **Financial Services 10.5%** |
| Blackrock, Inc.  | 14000 | 15484140 |
| Fidelity National Information Services, Inc.  | 155000 | 12308550 |
| Morgan Stanley  | 155000 | 22081300 |
| Visa, Inc., Class A  | 25000 | 8636750 |
|  |  | **58510740** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Food, Beverage & Tobacco 7.4%** | **Food, Beverage & Tobacco 7.4%** | **Food, Beverage & Tobacco 7.4%** |
| Altria Group, Inc.  | 85000 | 5264900 |
| Coca-Cola Co.  | 245000 | 16633050 |
| Constellation Brands, Inc., Class A  | 15000 | 2505600 |
| Philip Morris International, Inc.  | 105000 | 17225250 |
|  |  | **41628800** |
| **Health Care Equipment & Services 5.4%** | **Health Care Equipment & Services 5.4%** | **Health Care Equipment & Services 5.4%** |
| Abbott Laboratories  | 72000 | 9085680 |
| Becton Dickinson & Co.  | 31000 | 5525750 |
| CVS Health Corp.  | 50000 | 3105000 |
| Medtronic PLC  | 85000 | 7670400 |
| UnitedHealth Group, Inc.  | 20000 | 4991200 |
|  |  | **30378030** |
| **Household & Personal Products 3.3%** | **Household & Personal Products 3.3%** | **Household & Personal Products 3.3%** |
| Kenvue, Inc.  | 280000 | 6003200 |
| Procter & Gamble Co.  | 82000 | 12338540 |
|  |  | **18341740** |
| **Insurance 3.3%** | **Insurance 3.3%** | **Insurance 3.3%** |
| Allstate Corp.  | 40000 | 8130000 |
| Cincinnati Financial Corp.  | 30000 | 4425300 |
| Progressive Corp.  | 25000 | 6051000 |
|  |  | **18606300** |
| **Materials 0.7%** | **Materials 0.7%** | **Materials 0.7%** |
| PPG Industries, Inc.  | 35000 | **3692500** |
| **Media & Entertainment 2.8%** | **Media & Entertainment 2.8%** | **Media & Entertainment 2.8%** |
| Alphabet, Inc., Class A  | 30000 | 5757000 |
| Comcast Corp., Class A  | 260000 | 8639800 |
| Omnicom Group, Inc.  | 20000 | 1441000 |
|  |  | **15837800** |
| **Pharmaceuticals, Biotechnology & Life Sciences 5.3%** | **Pharmaceuticals, Biotechnology & Life Sciences 5.3%** | **Pharmaceuticals, Biotechnology & Life Sciences 5.3%** |
| AbbVie, Inc.  | 60000 | 11341200 |
| Johnson & Johnson  | 72310 | 11912349 |
| Merck & Co., Inc.  | 30000 | 2343600 |
| Pfizer, Inc.  | 170000 | 3959300 |
|  |  | **29556449** |
| **Semiconductors & Semiconductor Equipment 4.4%** | **Semiconductors & Semiconductor Equipment 4.4%** | **Semiconductors & Semiconductor Equipment 4.4%** |
| Broadcom, Inc.  | 70000 | 20559000 |
| Texas Instruments, Inc.  | 22000 | 3983320 |
|  |  | **24542320** |

---

**3**

------

Schwab Dividend Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Software & Services 6.9%** | **Software & Services 6.9%** | **Software & Services 6.9%** |
| Accenture PLC, Class A  | 20000 | 5342000 |
| International Business Machines Corp.  | 55000 | 13923250 |
| Microsoft Corp.  | 36000 | 19206000 |
|  |  | **38471250** |
| **Technology Hardware & Equipment 2.8%** | **Technology Hardware & Equipment 2.8%** | **Technology Hardware & Equipment 2.8%** |
| Apple, Inc.  | 26000 | 5396820 |
| Cisco Systems, Inc.  | 150000 | 10212000 |
|  |  | **15608820** |
| **Telecommunication Services 2.1%** | **Telecommunication Services 2.1%** | **Telecommunication Services 2.1%** |
| Verizon Communications, Inc.  | 275000 | **11759000** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Transportation 0.3%** | **Transportation 0.3%** | **Transportation 0.3%** |
| United Parcel Service, Inc., Class B  | 21500 | **1852440** |
| **Utilities 5.0%** | **Utilities 5.0%** | **Utilities 5.0%** |
| Duke Energy Corp.  | 127500 | 15509100 |
| Eversource Energy  | 80000 | 5288000 |
| NextEra Energy, Inc.  | 100000 | 7106000 |
|  |  | **27903100** |
| **Total Common Stocks**<br> **(Cost $361,484,652)** | **Total Common Stocks**<br> **(Cost $361,484,652)** | **549520593** |
| **Total Investments in Securities**<br> **(Cost $361,484,652)** | **Total Investments in Securities**<br> **(Cost $361,484,652)** | **549520593** |

---

------

The following is a summary of the inputs used to value the fund's investments as of July 31, 2025 (see notes to portfolio holdings for additional information):

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $549520593 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $549520593 |
| **Total** | **$549520593** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$549520593** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**4**

------

Schwab Capital Trust

Schwab Large-Cap Growth Fund

------

**Portfolio Holdings** as of July 31, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 99.6% OF NET ASSETS | **COMMON STOCKS** 99.6% OF NET ASSETS | **COMMON STOCKS** 99.6% OF NET ASSETS |
| **Automobiles & Components 2.4%** | **Automobiles & Components 2.4%** | **Automobiles & Components 2.4%** |
| Tesla, Inc. \* | 42749 | **13178234** |
| **Capital Goods 4.7%** | **Capital Goods 4.7%** | **Capital Goods 4.7%** |
| Caterpillar, Inc.  | 11998 | 5255364 |
| GE Vernova, Inc.  | 2570 | 1696945 |
| General Electric Co.  | 8062 | 2185447 |
| Parker-Hannifin Corp.  | 9064 | 6633942 |
| Quanta Services, Inc.  | 9885 | 4014595 |
| Vertiv Holdings Co., Class A  | 41403 | 6028277 |
|  |  | **25814570** |
| **Commercial & Professional Services 0.6%** | **Commercial & Professional Services 0.6%** | **Commercial & Professional Services 0.6%** |
| Republic Services, Inc., Class A  | 13337 | **3076179** |
| **Consumer Discretionary Distribution & Retail 9.1%** | **Consumer Discretionary Distribution & Retail 9.1%** | **Consumer Discretionary Distribution & Retail 9.1%** |
| Amazon.com, Inc. \* | 131419 | 30766502 |
| Home Depot, Inc.  | 18915 | 6951452 |
| O'Reilly Automotive, Inc. \* | 60600 | 5958192 |
| TJX Cos., Inc.  | 48942 | 6094747 |
|  |  | **49770893** |
| **Consumer Services 1.2%** | **Consumer Services 1.2%** | **Consumer Services 1.2%** |
| Booking Holdings, Inc.  | 955 | 5256377 |
| DoorDash, Inc., Class A \* | 5208 | 1303302 |
|  |  | **6559679** |
| **Consumer Staples Distribution & Retail 2.0%** | **Consumer Staples Distribution & Retail 2.0%** | **Consumer Staples Distribution & Retail 2.0%** |
| Costco Wholesale Corp.  | 8843 | 8309236 |
| Walmart, Inc.  | 28014 | 2744812 |
|  |  | **11054048** |
| **Energy 0.3%** | **Energy 0.3%** | **Energy 0.3%** |
| EOG Resources, Inc.  | 14768 | **1772455** |
| **Financial Services 5.5%** | **Financial Services 5.5%** | **Financial Services 5.5%** |
| American Express Co.  | 18405 | 5508801 |
| Blackrock, Inc.  | 2062 | 2280593 |
| Blackstone, Inc.  | 12491 | 2160443 |
| Interactive Brokers Group, Inc., Class A  | 51824 | 3397581 |
| Mastercard, Inc., Class A  | 14854 | 8414345 |
| Visa, Inc., Class A  | 24440 | 8443287 |
|  |  | **30205050** |
| **Food, Beverage & Tobacco 1.0%** | **Food, Beverage & Tobacco 1.0%** | **Food, Beverage & Tobacco 1.0%** |
| Philip Morris International, Inc.  | 34383 | **5640531** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Health Care Equipment & Services 2.2%** | **Health Care Equipment & Services 2.2%** | **Health Care Equipment & Services 2.2%** |
| Boston Scientific Corp. \* | 49610 | 5205081 |
| Intuitive Surgical, Inc. \* | 13548 | 6517808 |
|  |  | **11722889** |
| **Insurance 1.3%** | **Insurance 1.3%** | **Insurance 1.3%** |
| Arthur J Gallagher & Co.  | 13345 | 3833351 |
| Progressive Corp.  | 14442 | 3495542 |
|  |  | **7328893** |
| **Media & Entertainment 13.0%** | **Media & Entertainment 13.0%** | **Media & Entertainment 13.0%** |
| Alphabet, Inc., Class A  | 133454 | 25609823 |
| Meta Platforms, Inc., Class A  | 42692 | 33019700 |
| Netflix, Inc. \* | 8854 | 10265328 |
| Spotify Technology SA \* | 3362 | 2106427 |
|  |  | **71001278** |
| **Pharmaceuticals, Biotechnology & Life Sciences 4.2%** | **Pharmaceuticals, Biotechnology & Life Sciences 4.2%** | **Pharmaceuticals, Biotechnology & Life Sciences 4.2%** |
| AbbVie, Inc.  | 14051 | 2655920 |
| Eli Lilly & Co.  | 18561 | 13736440 |
| Thermo Fisher Scientific, Inc.  | 5343 | 2498814 |
| Vertex Pharmaceuticals, Inc. \* | 9008 | 4115485 |
|  |  | **23006659** |
| **Semiconductors & Semiconductor Equipment 19.3%** | **Semiconductors & Semiconductor Equipment 19.3%** | **Semiconductors & Semiconductor Equipment 19.3%** |
| Advanced Micro Devices, Inc. \* | 35376 | 6237143 |
| Broadcom, Inc.  | 99786 | 29307148 |
| KLA Corp.  | 2590 | 2276688 |
| Lam Research Corp.  | 43231 | 4100028 |
| NVIDIA Corp.  | 322560 | 57373747 |
| Texas Instruments, Inc.  | 31965 | 5787583 |
|  |  | **105082337** |
| **Software & Services 22.1%** | **Software & Services 22.1%** | **Software & Services 22.1%** |
| Accenture PLC, Class A  | 16552 | 4421039 |
| Crowdstrike Holdings, Inc., Class A \* | 10692 | 4860263 |
| Datadog, Inc., Class A \* | 31836 | 4456403 |
| International Business Machines Corp.  | 19008 | 4811875 |
| Intuit, Inc.  | 8465 | 6646126 |
| Microsoft Corp.  | 99364 | 53010694 |
| Oracle Corp.  | 34209 | 8681218 |
| Palantir Technologies, Inc., Class A \* | 35355 | 5598464 |
| Palo Alto Networks, Inc. \* | 41199 | 7152146 |
| Salesforce, Inc.  | 33051 | 8538065 |
| ServiceNow, Inc. \* | 9192 | 8669159 |
| Synopsys, Inc. \* | 5560 | 3522093 |
|  |  | **120367545** |
| **Technology Hardware & Equipment 9.8%** | **Technology Hardware & Equipment 9.8%** | **Technology Hardware & Equipment 9.8%** |
| Amphenol Corp., Class A  | 74208 | 7903894 |
| Apple, Inc.  | 186176 | 38644552 |
| Arista Networks, Inc. \* | 57793 | 7121254 |
|  |  | **53669700** |

---

**5**

------

Schwab Large-Cap Growth Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Transportation 0.9%** | **Transportation 0.9%** | **Transportation 0.9%** |
| Uber Technologies, Inc. \* | 52644 | **4619511** |
| **Total Common Stocks**<br> **(Cost $226,557,734)** | **Total Common Stocks**<br> **(Cost $226,557,734)** | **543870451** |
| **Total Investments in Securities**<br> **(Cost $226,557,734)** | **Total Investments in Securities**<br> **(Cost $226,557,734)** | **543870451** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of July 31, 2025 (see notes to portfolio holdings for additional information):

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $543870451 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $543870451 |
| **Total** | **$543870451** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$543870451** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**6**

------

Schwab Capital Trust

Schwab Small-Cap Equity Fund

------

**Portfolio Holdings** as of July 31, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 95.1% OF NET ASSETS | **COMMON STOCKS** 95.1% OF NET ASSETS | **COMMON STOCKS** 95.1% OF NET ASSETS |
| **Automobiles & Components 1.2%** | **Automobiles & Components 1.2%** | **Automobiles & Components 1.2%** |
| &nbsp;&nbsp;&nbsp;&nbsp; American Axle & Manufacturing Holdings, <br> Inc. \*<br>| 410920 | 1828594 |
| Dana, Inc.  | 109278 | 1739706 |
| Dorman Products, Inc. \* | 10152 | 1224534 |
| Modine Manufacturing Co. \* | 16438 | 2211897 |
|  |  | **7004731** |
| **Banks 9.8%** | **Banks 9.8%** | **Banks 9.8%** |
| Ameris Bancorp  | 88783 | 6068318 |
| Associated Banc-Corp.  | 173993 | 4304587 |
| Axos Financial, Inc. \* | 34780 | 3003253 |
| BankUnited, Inc.  | 187808 | 6849358 |
| Cadence Bank  | 21770 | 758684 |
| Enterprise Financial Services Corp.  | 92746 | 5118652 |
| First Financial Corp.  | 26745 | 1432195 |
| Hancock Whitney Corp.  | 121741 | 7270372 |
| Hanmi Financial Corp.  | 67867 | 1548046 |
| Home BancShares, Inc.  | 18928 | 533012 |
| Hope Bancorp, Inc.  | 217140 | 2169229 |
| Independent Bank Corp.  | 5636 | 358168 |
| International Bancshares Corp.  | 71879 | 4900710 |
| OceanFirst Financial Corp.  | 46011 | 772065 |
| SouthState Corp.  | 8919 | 839902 |
| Trustmark Corp.  | 140248 | 5224238 |
| UMB Financial Corp.  | 23433 | 2577396 |
| Valley National Bancorp  | 570537 | 5288878 |
|  |  | **59017063** |
| **Capital Goods 12.6%** | **Capital Goods 12.6%** | **Capital Goods 12.6%** |
| Allient, Inc.  | 39495 | 1592043 |
| Applied Industrial Technologies, Inc.  | 4840 | 1314060 |
| Argan, Inc.  | 7118 | 1743768 |
| Array Technologies, Inc. \* | 69707 | 453095 |
| Atkore, Inc.  | 26175 | 2015998 |
| Atmus Filtration Technologies, Inc.  | 58971 | 2294562 |
| Bloom Energy Corp., Class A \* | 68396 | 2557326 |
| Blue Bird Corp. \* | 45077 | 2018999 |
| Comfort Systems USA, Inc.  | 8361 | 5880291 |
| Ducommun, Inc. \* | 15639 | 1422836 |
| EMCOR Group, Inc.  | 3421 | 2146643 |
| EnerSys  | 42135 | 3892010 |
| ESCO Technologies, Inc.  | 12576 | 2435971 |
| Federal Signal Corp.  | 18280 | 2313700 |
| FTAI Aviation Ltd.  | 5936 | 816853 |
| Griffon Corp.  | 36339 | 2953271 |
| Herc Holdings, Inc.  | 19885 | 2322767 |
| Hyster-Yale, Inc.  | 12128 | 509497 |
| IES Holdings, Inc. \* | 4762 | 1681319 |
| Leonardo DRS, Inc.  | 61956 | 2577370 |
| Moog, Inc., Class A  | 16392 | 3173163 |
| Mueller Industries, Inc.  | 30203 | 2578430 |
| Mueller Water Products, Inc., Class A  | 94221 | 2332912 |
| NEXTracker, Inc., Class A \* | 46641 | 2717305 |
| Powell Industries, Inc.  | 8201 | 1944457 |
| Power Solutions International, Inc. \**(a)* | 10296 | 965250 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Preformed Line Products Co.  | 5414 | 835543 |
| Primoris Services Corp.  | 30462 | 2868607 |
| Resideo Technologies, Inc. \* | 32493 | 887059 |
| REV Group, Inc.  | 55087 | 2729561 |
| SPX Technologies, Inc. \* | 15769 | 2876108 |
| Sterling Infrastructure, Inc. \* | 17107 | 4577662 |
| Thermon Group Holdings, Inc. \* | 78478 | 2219358 |
| V2X, Inc. \* | 4034 | 191131 |
| Watts Water Technologies, Inc., Class A  | 6465 | 1695899 |
|  |  | **75534824** |
| **Commercial & Professional Services 2.6%** | **Commercial & Professional Services 2.6%** | **Commercial & Professional Services 2.6%** |
| Cimpress PLC \* | 42954 | 2375786 |
| Deluxe Corp.  | 30096 | 484546 |
| ExlService Holdings, Inc. \* | 20242 | 879110 |
| HNI Corp.  | 9726 | 500305 |
| Huron Consulting Group, Inc. \* | 6585 | 869747 |
| IBEX Holdings Ltd. \* | 121775 | 3600887 |
| Interface, Inc., Class A  | 71042 | 1464886 |
| Legalzoom.com, Inc. \* | 83697 | 752436 |
| Maximus, Inc.  | 29194 | 2156269 |
| Pitney Bowes, Inc.  | 85043 | 966088 |
| Verra Mobility Corp., Class A \* | 59547 | 1504157 |
|  |  | **15554217** |
| **Consumer Discretionary Distribution & Retail 2.2%** | **Consumer Discretionary Distribution & Retail 2.2%** | **Consumer Discretionary Distribution & Retail 2.2%** |
| Abercrombie & Fitch Co., Class A \* | 14636 | 1405349 |
| Build-A-Bear Workshop, Inc.  | 22131 | 1122263 |
| Carvana Co., Class A \* | 1589 | 619980 |
| Group 1 Automotive, Inc.  | 6485 | 2672793 |
| Sally Beauty Holdings, Inc. \* | 139337 | 1357142 |
| Sonic Automotive, Inc., Class A  | 15155 | 1096464 |
| ThredUp, Inc., Class A \* | 52955 | 437408 |
| Upbound Group, Inc.  | 51820 | 1069306 |
| Urban Outfitters, Inc. \* | 23533 | 1771564 |
| Victoria's Secret & Co. \* | 38319 | 720397 |
| Warby Parker, Inc., Class A \* | 34525 | 826874 |
|  |  | **13099540** |
| **Consumer Durables & Apparel 2.6%** | **Consumer Durables & Apparel 2.6%** | **Consumer Durables & Apparel 2.6%** |
| Champion Homes, Inc. \* | 11267 | 686160 |
| Funko, Inc., Class A \* | 110905 | 425875 |
| Green Brick Partners, Inc. \* | 11961 | 740864 |
| JAKKS Pacific, Inc.  | 40204 | 712013 |
| Kontoor Brands, Inc.  | 36429 | 2027638 |
| M/I Homes, Inc. \* | 17609 | 2116426 |
| Peloton Interactive, Inc., Class A \* | 351990 | 2513209 |
| Taylor Morrison Home Corp., Class A \* | 53165 | 3151621 |
| Tri Pointe Homes, Inc. \* | 85131 | 2622035 |
| YETI Holdings, Inc. \* | 23139 | 850127 |
|  |  | **15845968** |
| **Consumer Services 3.8%** | **Consumer Services 3.8%** | **Consumer Services 3.8%** |
| Adtalem Global Education, Inc. \* | 8726 | 997120 |
| Brinker International, Inc. \* | 30081 | 4740766 |
| Cheesecake Factory, Inc. *(a)* | 19263 | 1231098 |
| Coursera, Inc. \* | 65301 | 825405 |

---

**7**

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Frontdoor, Inc. \* | 46080 | 2695680 |
| Life Time Group Holdings, Inc. \* | 77789 | 2234100 |
| Light & Wonder, Inc. \* | 9142 | 880557 |
| Monarch Casino & Resort, Inc.  | 30777 | 3168800 |
| Red Rock Resorts, Inc., Class A  | 8392 | 514849 |
| Rush Street Interactive, Inc. \* | 210894 | 4251623 |
| Udemy, Inc. \* | 70230 | 534450 |
| Universal Technical Institute, Inc. \* | 19168 | 617593 |
|  |  | **22692041** |
| **Consumer Staples Distribution & Retail 0.9%** | **Consumer Staples Distribution & Retail 0.9%** | **Consumer Staples Distribution & Retail 0.9%** |
| Sprouts Farmers Market, Inc. \* | 25293 | 3832901 |
| United Natural Foods, Inc. \* | 57773 | 1596846 |
|  |  | **5429747** |
| **Energy 4.4%** | **Energy 4.4%** | **Energy 4.4%** |
| Archrock, Inc.  | 37905 | 885461 |
| Berry Corp.  | 417850 | 1261907 |
| Bristow Group, Inc. \* | 18306 | 632838 |
| California Resources Corp.  | 36886 | 1777167 |
| Centrus Energy Corp., Class A \* | 4471 | 963053 |
| CVR Energy, Inc.  | 48284 | 1293046 |
| Gulfport Energy Corp. \* | 10196 | 1775429 |
| Helix Energy Solutions Group, Inc. \* | 371206 | 2201252 |
| Matador Resources Co.  | 34209 | 1706345 |
| Navigator Holdings Ltd.  | 81677 | 1288046 |
| Oceaneering International, Inc. \* | 91563 | 1986917 |
| Par Pacific Holdings, Inc. \* | 51981 | 1631164 |
| Peabody Energy Corp.  | 97580 | 1575917 |
| ProFrac Holding Corp., Class A \**(a)* | 107507 | 754699 |
| ProPetro Holding Corp. \* | 219307 | 1175486 |
| Riley Exploration Permian, Inc.  | 33053 | 867311 |
| Scorpio Tankers, Inc.  | 27207 | 1230028 |
| SM Energy Co.  | 16949 | 467623 |
| Teekay Corp. Ltd.  | 116448 | 838426 |
| Tidewater, Inc. \* | 34076 | 1704141 |
| Weatherford International PLC  | 8929 | 504935 |
|  |  | **26521191** |
| **Equity Real Estate Investment Trusts (REITs) 5.4%** | **Equity Real Estate Investment Trusts (REITs) 5.4%** | **Equity Real Estate Investment Trusts (REITs) 5.4%** |
| Alexander & Baldwin, Inc.  | 393867 | 7081729 |
| American Assets Trust, Inc.  | 252447 | 4804066 |
| American Healthcare REIT, Inc.  | 30517 | 1179177 |
| COPT Defense Properties  | 94332 | 2573377 |
| DiamondRock Hospitality Co.  | 694145 | 5358799 |
| Empire State Realty Trust, Inc., Class A  | 128232 | 928400 |
| Global Net Lease, Inc.  | 164848 | 1152287 |
| Innovative Industrial Properties, Inc.  | 27683 | 1431211 |
| LTC Properties, Inc.  | 42927 | 1461235 |
| Piedmont Realty Trust, Inc., Class A  | 123894 | 936639 |
| PotlatchDeltic Corp.  | 27368 | 1119078 |
| Ryman Hospitality Properties, Inc.  | 12020 | 1142621 |
| Sabra Health Care REIT, Inc.  | 52335 | 943600 |
| SL Green Realty Corp.  | 41271 | 2362765 |
|  |  | **32474984** |
| **Financial Services 6.3%** | **Financial Services 6.3%** | **Financial Services 6.3%** |
| BGC Group, Inc., Class A  | 194026 | 1798621 |
| Bread Financial Holdings, Inc.  | 70618 | 4328883 |
| Enact Holdings, Inc.  | 38303 | 1331412 |
| Enova International, Inc. \* | 54379 | 5685868 |
| Essent Group Ltd.  | 22531 | 1261511 |
| EVERTEC, Inc.  | 62579 | 2262231 |
| Jackson Financial, Inc., Class A  | 83270 | 7291121 |
| Moelis & Co., Class A  | 12390 | 869035 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| NCR Atleos Corp. \* | 45758 | 1400195 |
| NMI Holdings, Inc., Class A \* | 44510 | 1661113 |
| Pagseguro Digital Ltd., Class A  | 167501 | 1311533 |
| PROG Holdings, Inc.  | 36591 | 1165058 |
| Regional Management Corp.  | 20875 | 693885 |
| StoneX Group, Inc. \* | 5464 | 531319 |
| Victory Capital Holdings, Inc., Class A  | 21741 | 1498172 |
| Virtus Investment Partners, Inc.  | 17377 | 3359148 |
| World Acceptance Corp. \* | 7928 | 1247233 |
|  |  | **37696338** |
| **Food, Beverage & Tobacco 1.2%** | **Food, Beverage & Tobacco 1.2%** | **Food, Beverage & Tobacco 1.2%** |
| Cal-Maine Foods, Inc.  | 33871 | 3764423 |
| Dole PLC  | 69375 | 987900 |
| National Beverage Corp. \* | 24270 | 1112051 |
| Seneca Foods Corp., Class A \* | 9705 | 1016405 |
|  |  | **6880779** |
| **Health Care Equipment & Services 3.9%** | **Health Care Equipment & Services 3.9%** | **Health Care Equipment & Services 3.9%** |
| Avanos Medical, Inc. \* | 64720 | 722922 |
| Axogen, Inc. \* | 34985 | 457954 |
| Bioventus, Inc., Class A \* | 71532 | 466389 |
| BrightSpring Health Services, Inc. \* | 66206 | 1367154 |
| Ensign Group, Inc.  | 7632 | 1144800 |
| HealthEquity, Inc. \* | 28258 | 2741026 |
| Hims & Hers Health, Inc. \* | 29581 | 1957671 |
| iRhythm Technologies, Inc. \* | 6881 | 964579 |
| Lantheus Holdings, Inc. \* | 6102 | 434401 |
| LivaNova PLC \* | 20546 | 866836 |
| Novocure Ltd. \* | 69299 | 801789 |
| OmniAb, Inc., Class A \**(b)* | 5508 | 0 |
| OmniAb, Inc., Class B \**(b)* | 5508 | 0 |
| Option Care Health, Inc. \* | 83945 | 2463786 |
| Owens & Minor, Inc. \* | 90678 | 628398 |
| Pediatrix Medical Group, Inc. \* | 58989 | 722615 |
| Phreesia, Inc. \* | 72277 | 1948588 |
| QuidelOrtho Corp. \* | 60772 | 1398971 |
| Teladoc Health, Inc. \* | 158351 | 1141711 |
| Tenet Healthcare Corp. \* | 6508 | 1049610 |
| TruBridge, Inc. \* | 19265 | 401097 |
| UFP Technologies, Inc. \* | 1898 | 429688 |
| Waystar Holding Corp. \* | 29463 | 1089542 |
|  |  | **23199527** |
| **Insurance 2.3%** | **Insurance 2.3%** | **Insurance 2.3%** |
| CNO Financial Group, Inc.  | 130088 | 4792442 |
| Donegal Group, Inc., Class A  | 28397 | 487008 |
| Fidelis Insurance Holdings Ltd.  | 111656 | 1687122 |
| Genworth Financial, Inc., Class A \* | 170057 | 1336648 |
| Hamilton Insurance Group Ltd., Class B \* | 129544 | 2783901 |
| Mercury General Corp.  | 3684 | 255117 |
| Palomar Holdings, Inc. \* | 12643 | 1675071 |
| Selective Insurance Group, Inc.  | 8513 | 663759 |
|  |  | **13681068** |
| **Materials 3.0%** | **Materials 3.0%** | **Materials 3.0%** |
| Alpha Metallurgical Resources, Inc. \* | 10863 | 1282595 |
| Century Aluminum Co. \* | 38024 | 805348 |
| Coeur Mining, Inc. \* | 192373 | 1671721 |
| Commercial Metals Co.  | 10979 | 569371 |
| Constellium SE, Class A \* | 133047 | 1824074 |
| Hecla Mining Co.  | 230364 | 1322289 |
| Ingevity Corp. \* | 58280 | 2435521 |
| Materion Corp.  | 11183 | 1177570 |
| Mativ Holdings, Inc.  | 324520 | 2148323 |

---

**8**

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Minerals Technologies, Inc.  | 33339 | 1938663 |
| O-I Glass, Inc. \* | 49271 | 641016 |
| U.S. Lime & Minerals, Inc.  | 14687 | 1462532 |
| Worthington Steel, Inc.  | 15966 | 487282 |
|  |  | **17766305** |
| **Media & Entertainment 2.1%** | **Media & Entertainment 2.1%** | **Media & Entertainment 2.1%** |
| AMC Networks, Inc., Class A \* | 159656 | 956339 |
| Cargurus, Inc. \* | 88595 | 2907688 |
| EverQuote, Inc., Class A \* | 19206 | 472276 |
| Gray Media, Inc.  | 193978 | 874841 |
| Grindr, Inc. \* | 38030 | 664764 |
| Magnite, Inc. \* | 62421 | 1436307 |
| MediaAlpha, Inc., Class A \* | 39555 | 396341 |
| Playtika Holding Corp.  | 288390 | 1284778 |
| QuinStreet, Inc. \* | 48386 | 794014 |
| TEGNA, Inc.  | 37390 | 624413 |
| Thryv Holdings, Inc. \* | 88302 | 1162054 |
| Yelp, Inc., Class A \* | 36123 | 1243715 |
|  |  | **12817530** |
| **Pharmaceuticals, Biotechnology & Life Sciences 12.0%** | **Pharmaceuticals, Biotechnology & Life Sciences 12.0%** | **Pharmaceuticals, Biotechnology & Life Sciences 12.0%** |
| ACADIA Pharmaceuticals, Inc. \* | 41648 | 992472 |
| Adaptive Biotechnologies Corp. \* | 88800 | 909312 |
| ADMA Biologics, Inc. \* | 87072 | 1628246 |
| Akero Therapeutics, Inc. \* | 16488 | 805439 |
| Alkermes PLC \* | 55531 | 1471016 |
| Amicus Therapeutics, Inc. \* | 229358 | 1373854 |
| Amneal Pharmaceuticals, Inc. \* | 310651 | 2429291 |
| AnaptysBio, Inc. \* | 38847 | 953694 |
| ANI Pharmaceuticals, Inc. \* | 5291 | 335185 |
| Apogee Therapeutics, Inc. \* | 24190 | 925509 |
| Arcus Biosciences, Inc. \* | 84838 | 774571 |
| Arcutis Biotherapeutics, Inc. \* | 82694 | 1205678 |
| Ardelyx, Inc. \* | 227703 | 965461 |
| Arrowhead Pharmaceuticals, Inc. \* | 72777 | 1149877 |
| Aurinia Pharmaceuticals, Inc. \* | 215228 | 1989783 |
| Avidity Biosciences, Inc. \* | 14736 | 540959 |
| Axsome Therapeutics, Inc. \* | 16814 | 1704603 |
| Beam Therapeutics, Inc. \* | 89277 | 1759650 |
| BioCryst Pharmaceuticals, Inc. \* | 237508 | 1933315 |
| Bridgebio Pharma, Inc. \* | 9654 | 456345 |
| CareDx, Inc. \* | 70934 | 871424 |
| Catalyst Pharmaceuticals, Inc. \* | 138234 | 2948531 |
| Cogent Biosciences, Inc. \* | 46125 | 526747 |
| Collegium Pharmaceutical, Inc. \* | 23343 | 697022 |
| Halozyme Therapeutics, Inc. \* | 15967 | 957541 |
| Harmony Biosciences Holdings, Inc. \* | 70897 | 2494156 |
| Indivior PLC \* | 112429 | 2271066 |
| Insmed, Inc. \* | 7216 | 774132 |
| Janux Therapeutics, Inc. \* | 13401 | 321825 |
| Kiniksa Pharmaceuticals International PLC \* | 70315 | 2127732 |
| Krystal Biotech, Inc. \* | 4664 | 717650 |
| Kymera Therapeutics, Inc. \* | 13244 | 579425 |
| Madrigal Pharmaceuticals, Inc. \* | 3587 | 1085103 |
| Medpace Holdings, Inc. \* | 3362 | 1436246 |
| Mesa Laboratories, Inc.  | 12292 | 940092 |
| Mirum Pharmaceuticals, Inc. \* | 30957 | 1599858 |
| Myriad Genetics, Inc. \* | 182219 | 699721 |
| Nurix Therapeutics, Inc. \* | 262664 | 2957597 |
| Organogenesis Holdings, Inc., Class A \* | 359577 | 1661246 |
| Pacira BioSciences, Inc. \* | 37296 | 786573 |
| Phibro Animal Health Corp., Class A  | 60529 | 1604018 |
| Prestige Consumer Healthcare, Inc. \* | 30263 | 2237949 |
| PTC Therapeutics, Inc. \* | 52115 | 2715713 |
| Rhythm Pharmaceuticals, Inc. \* | 14031 | 1195862 |
| Rigel Pharmaceuticals, Inc. \* | 31226 | 657620 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Supernus Pharmaceuticals, Inc. \* | 74507 | 2615196 |
| Tarsus Pharmaceuticals, Inc. \* | 9918 | 385017 |
| TG Therapeutics, Inc. \* | 31949 | 1134189 |
| Travere Therapeutics, Inc. \* | 117613 | 1817121 |
| Twist Bioscience Corp. \* | 71562 | 2402336 |
| Vaxcyte, Inc. \* | 48374 | 1642297 |
| Veracyte, Inc. \* | 63703 | 1497658 |
| Vir Biotechnology, Inc. \* | 117062 | 593504 |
| WaVe Life Sciences Ltd. \* | 53109 | 430183 |
| Xeris Biopharma Holdings, Inc. \* | 106962 | 544437 |
|  |  | **72231047** |
| **Real Estate Management & Development 1.0%** | **Real Estate Management & Development 1.0%** | **Real Estate Management & Development 1.0%** |
| Compass, Inc., Class A \* | 128363 | 1019202 |
| Cushman & Wakefield PLC \* | 131923 | 1608141 |
| Newmark Group, Inc., Class A  | 239539 | 3633807 |
|  |  | **6261150** |
| **Semiconductors & Semiconductor Equipment 2.4%** | **Semiconductors & Semiconductor Equipment 2.4%** | **Semiconductors & Semiconductor Equipment 2.4%** |
| Ambarella, Inc. \* | 13566 | 896577 |
| Credo Technology Group Holding Ltd. \* | 38153 | 4255967 |
| FormFactor, Inc. \* | 22304 | 633656 |
| Impinj, Inc. \* | 6388 | 987457 |
| Onto Innovation, Inc. \* | 7084 | 671209 |
| Penguin Solutions, Inc. \* | 106051 | 2499622 |
| Photronics, Inc. \* | 20116 | 409562 |
| Semtech Corp. \* | 59979 | 3064927 |
| Silicon Laboratories, Inc. \* | 7996 | 1053633 |
|  |  | **14472610** |
| **Software & Services 6.4%** | **Software & Services 6.4%** | **Software & Services 6.4%** |
| 8x8, Inc. \* | 264099 | 512352 |
| ACI Worldwide, Inc. \* | 49701 | 2115275 |
| Alarm.com Holdings, Inc. \* | 20606 | 1125706 |
| Appfolio, Inc., Class A \* | 10519 | 2812570 |
| Asana, Inc., Class A \* | 140452 | 2061835 |
| BigCommerce Holdings, Inc. \* | 156167 | 746478 |
| Blackbaud, Inc. \* | 35763 | 2411142 |
| BlackLine, Inc. \* | 9532 | 512631 |
| Box, Inc., Class A \* | 23864 | 766034 |
| Clear Secure, Inc., Class A  | 24193 | 711516 |
| Commvault Systems, Inc. \* | 16878 | 3205976 |
| DigitalOcean Holdings, Inc. \* | 16933 | 471753 |
| eGain Corp. \* | 98492 | 608681 |
| Freshworks, Inc., Class A \* | 56865 | 738676 |
| Intapp, Inc. \* | 64768 | 2593958 |
| Life360, Inc. \* | 4296 | 329031 |
| OneSpan, Inc.  | 63416 | 935386 |
| PagerDuty, Inc. \* | 63825 | 1028859 |
| PROS Holdings, Inc. \* | 69315 | 1087552 |
| Q2 Holdings, Inc. \* | 29781 | 2418217 |
| Qualys, Inc. \* | 12148 | 1616534 |
| RingCentral, Inc., Class A \* | 127614 | 3252881 |
| SEMrush Holdings, Inc., Class A \* | 88510 | 793050 |
| Sprout Social, Inc., Class A \* | 68244 | 1170385 |
| SPS Commerce, Inc. \* | 7776 | 846534 |
| Tenable Holdings, Inc. \* | 24748 | 774860 |
| Unisys Corp. \* | 130262 | 537982 |
| Verint Systems, Inc. \* | 25846 | 550003 |
| Weave Communications, Inc. \* | 71409 | 521286 |
| Workiva, Inc., Class A \* | 8137 | 519385 |
| Zeta Global Holdings Corp., Class A \* | 48221 | 754659 |
|  |  | **38531187** |

---

**9**

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Technology Hardware & Equipment 4.9%** | **Technology Hardware & Equipment 4.9%** | **Technology Hardware & Equipment 4.9%** |
| ADTRAN Holdings, Inc. \* | 70471 | 654676 |
| Advanced Energy Industries, Inc.  | 17533 | 2435684 |
| Arlo Technologies, Inc. \* | 68549 | 1110494 |
| Badger Meter, Inc.  | 11560 | 2182066 |
| Belden, Inc.  | 11466 | 1417771 |
| CommScope Holding Co., Inc. \* | 49386 | 404965 |
| Daktronics, Inc. \* | 78021 | 1265501 |
| Extreme Networks, Inc. \* | 131987 | 2330890 |
| Fabrinet \* | 15406 | 4987384 |
| Harmonic, Inc. \* | 117094 | 996470 |
| Itron, Inc. \* | 14851 | 1849544 |
| Mirion Technologies, Inc., Class A \* | 77075 | 1722626 |
| Napco Security Technologies, Inc.  | 37576 | 1147195 |
| NetScout Systems, Inc. \* | 21243 | 455025 |
| OSI Systems, Inc. \* | 12049 | 2662949 |
| Plexus Corp. \* | 20901 | 2664878 |
| TTM Technologies, Inc. \* | 21277 | 1005338 |
| Xerox Holdings Corp.  | 58491 | 236889 |
|  |  | **29530345** |
| **Telecommunication Services 1.0%** | **Telecommunication Services 1.0%** | **Telecommunication Services 1.0%** |
| Bandwidth, Inc., Class A \* | 68488 | 952668 |
| IDT Corp., Class B  | 65833 | 3878222 |
| Lumen Technologies, Inc. \* | 302598 | 1346561 |
|  |  | **6177451** |
| **Transportation 1.2%** | **Transportation 1.2%** | **Transportation 1.2%** |
| Costamare Bulkers Holdings Ltd. \* | 35459 | 319131 |
| Costamare, Inc.  | 33634 | 339367 |
| Hertz Global Holdings, Inc. \* | 91448 | 586182 |
| Matson, Inc.  | 9864 | 1053278 |
| SkyWest, Inc. \* | 41524 | 4815123 |
|  |  | **7113081** |
| **Utilities 1.9%** | **Utilities 1.9%** | **Utilities 1.9%** |
| Avista Corp.  | 62703 | 2338822 |
| Clearway Energy, Inc., Class A  | 36694 | 1129441 |
| Hawaiian Electric Industries, Inc. \* | 193319 | 2072380 |
| MGE Energy, Inc.  | 5485 | 465896 |
| Middlesex Water Co.  | 23454 | 1210226 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Northwestern Energy Group, Inc.  | 5094 | 273548 |
| Otter Tail Corp.  | 6179 | 476895 |
| Portland General Electric Co.  | 27317 | 1123275 |
| Southwest Gas Holdings, Inc.  | 20396 | 1593744 |
| Spire, Inc.  | 5685 | 423362 |
|  |  | **11107589** |
| **Total Common Stocks**<br> **(Cost $513,568,339)** | **Total Common Stocks**<br> **(Cost $513,568,339)** | **570640313** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **SHORT-TERM INVESTMENTS** 0.5% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.5% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.5% OF NET ASSETS |
| **Money Market Funds 0.5%** | **Money Market Funds 0.5%** | **Money Market Funds 0.5%** |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional U.S. Government <br> Money Market Fund, Premier Class <br> 4.25% *(c)(d)*<br>| 2914555 | **2914555** |
| **Total Short-Term Investments**<br> **(Cost $2,914,555)** | **Total Short-Term Investments**<br> **(Cost $2,914,555)** | **2914555** |
| **Total Investments in Securities**<br> **(Cost $516,482,894)** | **Total Investments in Securities**<br> **(Cost $516,482,894)** | **573554868** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | NUMBER OF<br> CONTRACTS<br>| NOTIONAL<br> AMOUNT<br> ($)<br>| CURRENT VALUE/<br> UNREALIZED<br> APPRECIATION<br> ($)<br>|
| **FUTURES CONTRACTS** | **FUTURES CONTRACTS** | **FUTURES CONTRACTS** | **FUTURES CONTRACTS** |
| **Long** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Russell 2000 Index, e-mini, <br> expires 09/19/25<br>| 240 | 26642400 | **1218859** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

*(a)* All or a portion of this security is on loan. Securities on loan were valued at $2,795,824. 

*(b)* Fair valued using significant unobservable inputs (see notes to portfolio holdings for additional information). 

*(c)* The rate shown is the annualized 7-day yield.

*(d)* Security purchased with cash collateral received for securities on loan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

REIT — Real Estate Investment Trust

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of July 31, 2025 (see notes to portfolio holdings for additional information):

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $547440786 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $547440786 |
| &nbsp;&nbsp;&nbsp;&nbsp; Health Care Equipment & Services | 23199527 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 0 <br><sup>\*</sup><br>| &nbsp;&nbsp;&nbsp; 23199527 |
| Short-Term Investments<sup>1</sup> <br>| 2914555 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2914555 |
| Futures Contracts<sup>2</sup> <br>| 1218859 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1218859 |
| **Total** | **$574773727** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$0** | &nbsp;&nbsp; **$574773727** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>\*</sup> Level 3 amount shown includes securities determined to have no value at July 31, 2025.

<sup>1</sup> As categorized in the Portfolio Holdings. 

<sup>2</sup> Futures contracts are reported at cumulative unrealized appreciation or depreciation.

**10**

------

Schwab Capital Trust

Schwab Health Care Fund

------

**Portfolio Holdings** as of July 31, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 99.5% OF NET ASSETS | **COMMON STOCKS** 99.5% OF NET ASSETS | **COMMON STOCKS** 99.5% OF NET ASSETS |
| **Australia 0.3%** | **Australia 0.3%** | **Australia 0.3%** |
| Pro Medicus Ltd.  | 8726 | **1791924** |
| **Belgium 0.3%** | **Belgium 0.3%** | **Belgium 0.3%** |
| UCB SA  | 9560 | **2054012** |
| **China 0.8%** | **China 0.8%** | **China 0.8%** |
| 3SBio, Inc. \* | 90000 | 363841 |
| Consun Pharmaceutical Group Ltd.  | 730000 | 1280430 |
| Hansoh Pharmaceutical Group Co. Ltd.  | 710000 | 3189795 |
| &nbsp;&nbsp;&nbsp;&nbsp; Livzon Pharmaceutical Group, Inc., <br> H Shares <br>| 12300 | 58876 |
|  |  | **4892942** |
| **Denmark 1.6%** | **Denmark 1.6%** | **Denmark 1.6%** |
| Demant AS \* | 15150 | 573997 |
| Novo Nordisk AS, Class B  | 195625 | 9098121 |
|  |  | **9672118** |
| **France 1.5%** | **France 1.5%** | **France 1.5%** |
| BioMerieux  | 12745 | 1823609 |
| EssilorLuxottica SA  | 17051 | 5070189 |
| Ipsen SA  | 21090 | 2485079 |
|  |  | **9378877** |
| **Germany 0.1%** | **Germany 0.1%** | **Germany 0.1%** |
| Eckert & Ziegler SE  | 4081 | **310454** |
| **Hong Kong 0.4%** | **Hong Kong 0.4%** | **Hong Kong 0.4%** |
| &nbsp;&nbsp;&nbsp;&nbsp; United Laboratories International Holdings <br> Ltd. <br>| 1424000 | **2669362** |
| **Ireland 3.6%** | **Ireland 3.6%** | **Ireland 3.6%** |
| Medtronic PLC  | 247047 | **22293521** |
| **Italy 0.3%** | **Italy 0.3%** | **Italy 0.3%** |
| &nbsp;&nbsp;&nbsp;&nbsp; Recordati Industria Chimica e Farmaceutica <br> SpA <br>| 35927 | **2060546** |
| **Japan 3.2%** | **Japan 3.2%** | **Japan 3.2%** |
| Alfresa Holdings Corp.  | 34100 | 494995 |
| As One Corp.  | 30000 | 471443 |
| Daiichi Sankyo Co. Ltd.  | 167000 | 4096831 |
| Hoya Corp.  | 69000 | 8705225 |
| Kissei Pharmaceutical Co. Ltd.  | 15000 | 441924 |
| Santen Pharmaceutical Co. Ltd.  | 380000 | 4198587 |
| Shionogi & Co. Ltd.  | 74000 | 1237599 |
|  |  | **19646604** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Netherlands 0.5%** | **Netherlands 0.5%** | **Netherlands 0.5%** |
| Qiagen NV  | 61243 | **3021730** |
| **New Zealand 0.1%** | **New Zealand 0.1%** | **New Zealand 0.1%** |
| Fisher & Paykel Healthcare Corp. Ltd.  | 28477 | **617349** |
| **Republic of Korea 1.3%** | **Republic of Korea 1.3%** | **Republic of Korea 1.3%** |
| Classys, Inc.  | 73910 | 3058083 |
| Hugel, Inc. \* | 12409 | 2995270 |
| Samsung Biologics Co. Ltd. \* | 2520 | 1925349 |
|  |  | **7978702** |
| **Sweden 0.5%** | **Sweden 0.5%** | **Sweden 0.5%** |
| Ambea AB  | 86962 | 1094026 |
| Swedish Orphan Biovitrum AB \* | 60116 | 1652979 |
|  |  | **2747005** |
| **Switzerland 5.4%** | **Switzerland 5.4%** | **Switzerland 5.4%** |
| Galenica AG  | 7332 | 778143 |
| Novartis AG  | 186482 | 21237884 |
| Roche Holding AG  | 35909 | 11206230 |
|  |  | **33222257** |
| **United Kingdom 3.3%** | **United Kingdom 3.3%** | **United Kingdom 3.3%** |
| AstraZeneca PLC  | 90641 | 13223764 |
| GSK PLC  | 362548 | 6668701 |
|  |  | **19892465** |
| **United States 76.3%** | **United States 76.3%** | **United States 76.3%** |
| Abbott Laboratories  | 155023 | 19562352 |
| AbbVie, Inc.  | 176334 | 33330653 |
| ADMA Biologics, Inc. \* | 225013 | 4207743 |
| Agilent Technologies, Inc.  | 5272 | 605278 |
| Amgen, Inc.  | 74500 | 21984950 |
| ANI Pharmaceuticals, Inc. \* | 91556 | 5800073 |
| Becton Dickinson & Co.  | 38551 | 6871716 |
| Bio-Techne Corp.  | 35888 | 1964150 |
| Boston Scientific Corp. \* | 148876 | 15620070 |
| Bristol-Myers Squibb Co.  | 85750 | 3713833 |
| Cardinal Health, Inc.  | 18910 | 2935210 |
| Catalyst Pharmaceuticals, Inc. \* | 176923 | 3773768 |
| Cencora, Inc.  | 33083 | 9464385 |
| Cigna Group  | 40788 | 10905895 |
| CVS Health Corp.  | 42519 | 2640430 |
| Danaher Corp.  | 19100 | 3765756 |
| DaVita, Inc. \* | 20282 | 2846984 |
| Eli Lilly & Co.  | 85532 | 63299667 |
| Encompass Health Corp.  | 40593 | 4469695 |
| Envista Holdings Corp. \* | 67600 | 1276964 |
| Exelixis, Inc. \* | 191686 | 6942867 |
| GE HealthCare Technologies, Inc.  | 64608 | 4607843 |
| Gilead Sciences, Inc.  | 171207 | 19224834 |
| HCA Healthcare, Inc.  | 6463 | 2287837 |
| HealthEquity, Inc. \* | 41561 | 4031417 |
| Incyte Corp. \* | 14800 | 1108372 |

---

**11**

------

Schwab Health Care Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Innoviva, Inc. \* | 37476 | 680939 |
| Integer Holdings Corp. \* | 8800 | 954888 |
| Intuitive Surgical, Inc. \* | 7152 | 3440756 |
| IQVIA Holdings, Inc. \* | 50629 | 9409906 |
| Johnson & Johnson  | 206798 | 34067903 |
| McKesson Corp.  | 14760 | 10236650 |
| Merck & Co., Inc.  | 202766 | 15840080 |
| Merit Medical Systems, Inc. \* | 26699 | 2265677 |
| Mettler-Toledo International, Inc. \* | 9281 | 11449784 |
| Natera, Inc. \* | 11800 | 1577188 |
| Niagen Bioscience, Inc. \* | 32598 | 304791 |
| Pfizer, Inc.  | 237075 | 5521477 |
| Prestige Consumer Healthcare, Inc. \* | 77273 | 5714338 |
| ResMed, Inc.  | 4991 | 1357253 |
| STERIS PLC  | 27020 | 6119760 |
| Stryker Corp.  | 65457 | 25706928 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Thermo Fisher Scientific, Inc.  | 54777 | 25618107 |
| United Therapeutics Corp. \* | 21885 | 6011809 |
| UnitedHealth Group, Inc.  | 89803 | 22411237 |
| Veracyte, Inc. \* | 99661 | 2343030 |
| Vertex Pharmaceuticals, Inc. \* | 29206 | 13343345 |
| Waters Corp. \* | 7429 | 2145198 |
| Zoetis, Inc.  | 19828 | 2890724 |
|  |  | **466654510** |
| **Total Common Stocks**<br> **(Cost $421,395,559)** | **Total Common Stocks**<br> **(Cost $421,395,559)** | **608904378** |
| **Total Investments in Securities**<br> **(Cost $421,395,559)** | **Total Investments in Securities**<br> **(Cost $421,395,559)** | **608904378** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of July 31, 2025 (see notes to portfolio holdings for additional information):

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $492587110 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $492587110 |
| &nbsp;&nbsp;&nbsp;&nbsp; Australia |  | &nbsp;&nbsp;&nbsp; 1791924 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1791924 |
| &nbsp;&nbsp;&nbsp;&nbsp; Belgium |  | &nbsp;&nbsp;&nbsp; 2054012 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2054012 |
| &nbsp;&nbsp;&nbsp;&nbsp; China |  | &nbsp;&nbsp;&nbsp; 4892942 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 4892942 |
| &nbsp;&nbsp;&nbsp;&nbsp; Denmark |  | &nbsp;&nbsp;&nbsp; 9672118 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 9672118 |
| &nbsp;&nbsp;&nbsp;&nbsp; France |  | &nbsp;&nbsp;&nbsp; 9378877 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 9378877 |
| &nbsp;&nbsp;&nbsp;&nbsp; Germany |  | &nbsp;&nbsp;&nbsp; 310454 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 310454 |
| &nbsp;&nbsp;&nbsp;&nbsp; Hong Kong |  | &nbsp;&nbsp;&nbsp; 2669362 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2669362 |
| &nbsp;&nbsp;&nbsp;&nbsp; Italy |  | &nbsp;&nbsp;&nbsp; 2060546 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2060546 |
| &nbsp;&nbsp;&nbsp;&nbsp; Japan |  | &nbsp;&nbsp;&nbsp; 19646604 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 19646604 |
| &nbsp;&nbsp;&nbsp;&nbsp; Republic of Korea |  | &nbsp;&nbsp;&nbsp; 7978702 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 7978702 |
| &nbsp;&nbsp;&nbsp;&nbsp; Sweden |  | &nbsp;&nbsp;&nbsp; 2747005 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2747005 |
| &nbsp;&nbsp;&nbsp;&nbsp; Switzerland |  | &nbsp;&nbsp;&nbsp; 33222257 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 33222257 |
| &nbsp;&nbsp;&nbsp;&nbsp; United Kingdom |  | &nbsp;&nbsp;&nbsp; 19892465 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 19892465 |
| **Total** | **$492587110** | &nbsp;&nbsp; **$116317268** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$608904378** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**12**

------

Schwab Capital Trust

Schwab International Core Equity Fund

------

**Portfolio Holdings** as of July 31, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 99.3% OF NET ASSETS | **COMMON STOCKS** 99.3% OF NET ASSETS | **COMMON STOCKS** 99.3% OF NET ASSETS |
| **Australia 4.8%** | **Australia 4.8%** | **Australia 4.8%** |
| AGL Energy Ltd.  | 1070892 | 6673903 |
| ANZ Group Holdings Ltd.  | 24622 | 483170 |
| Aristocrat Leisure Ltd.  | 67704 | 3031574 |
| BHP Group Ltd.  | 167183 | 4222242 |
| Commonwealth Bank of Australia  | 16439 | 1866312 |
| Fortescue Ltd.  | 38469 | 435248 |
| JB Hi-Fi Ltd.  | 44131 | 3143098 |
| Northern Star Resources Ltd.  | 368085 | 3657045 |
| QBE Insurance Group Ltd.  | 327147 | 4852969 |
| Suncorp Group Ltd.  | 133766 | 1793101 |
| Telstra Group Ltd.  | 1632195 | 5201937 |
| Westpac Banking Corp.  | 15003 | 323917 |
|  |  | **35684516** |
| **Belgium 0.6%** | **Belgium 0.6%** | **Belgium 0.6%** |
| Anheuser-Busch InBev SA  | 77406 | **4450276** |
| **Brazil 0.5%** | **Brazil 0.5%** | **Brazil 0.5%** |
| BB Seguridade Participacoes SA  | 663800 | **3994975** |
| **Canada 1.5%** | **Canada 1.5%** | **Canada 1.5%** |
| Constellation Software, Inc.  | 300 | 1034991 |
| Finning International, Inc.  | 152015 | 6624326 |
| Suncor Energy, Inc.  | 37800 | 1490885 |
| Toronto-Dominion Bank  | 29500 | 2148629 |
|  |  | **11298831** |
| **China 2.0%** | **China 2.0%** | **China 2.0%** |
| China Hongqiao Group Ltd.  | 293500 | 774222 |
| NetEase, Inc.  | 109000 | 2849504 |
| PetroChina Co. Ltd., H Shares  | 5116000 | 4999515 |
| Tencent Holdings Ltd.  | 87700 | 6140070 |
|  |  | **14763311** |
| **Denmark 1.7%** | **Denmark 1.7%** | **Denmark 1.7%** |
| Genmab AS \* | 8002 | 1722810 |
| Novo Nordisk AS, Class B  | 68500 | 3185795 |
| Pandora AS  | 16552 | 2732662 |
| Rockwool AS, Class B  | 119920 | 5254968 |
|  |  | **12896235** |
| **Finland 1.1%** | **Finland 1.1%** | **Finland 1.1%** |
| Nordea Bank Abp  | 353215 | 5157187 |
| Wartsila OYJ Abp  | 113460 | 3134718 |
|  |  | **8291905** |
| **France 9.2%** | **France 9.2%** | **France 9.2%** |
| BNP Paribas SA  | 147100 | 13412317 |
| &nbsp;&nbsp;&nbsp;&nbsp; Cie Generale des Etablissements Michelin <br> SCA <br>| 138583 | 4930294 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Credit Agricole SA  | 621238 | 11433583 |
| Eiffage SA  | 11616 | 1559278 |
| Engie SA  | 446172 | 10029150 |
| Hermes International SCA  | 890 | 2176484 |
| Ipsen SA  | 67349 | 7935874 |
| LVMH Moet Hennessy Louis Vuitton SE  | 2765 | 1484284 |
| Safran SA  | 18655 | 6151508 |
| Sanofi SA  | 66492 | 5969029 |
| Societe Generale SA  | 60184 | 3841455 |
|  |  | **68923256** |
| **Germany 10.0%** | **Germany 10.0%** | **Germany 10.0%** |
| Allianz SE  | 31013 | 12255644 |
| Deutsche Post AG  | 31871 | 1428003 |
| Deutsche Telekom AG  | 399848 | 14340907 |
| Heidelberg Materials AG  | 52370 | 12081470 |
| Henkel AG & Co. KGaA  | 9744 | 692899 |
| Mercedes-Benz Group AG  | 16724 | 946917 |
| &nbsp;&nbsp;&nbsp;&nbsp; Muenchener <br> Rueckversicherungs-Gesellschaft AG in <br> Muenchen <br>| 8256 | 5404960 |
| Rheinmetall AG  | 602 | 1191657 |
| SAP SE  | 50882 | 14549989 |
| Siemens AG  | 35468 | 9033810 |
| Siemens Energy AG \* | 28852 | 3340446 |
|  |  | **75266702** |
| **Greece 1.1%** | **Greece 1.1%** | **Greece 1.1%** |
| OPAP SA  | 256250 | 5749220 |
| Piraeus Financial Holdings SA \* | 307458 | 2364177 |
|  |  | **8113397** |
| **Hong Kong 1.9%** | **Hong Kong 1.9%** | **Hong Kong 1.9%** |
| AIA Group Ltd.  | 176400 | 1644783 |
| Hong Kong Exchanges & Clearing Ltd.  | 24600 | 1331323 |
| Jardine Matheson Holdings Ltd.  | 63600 | 3453566 |
| Orient Overseas International Ltd.  | 128500 | 2312007 |
| Sino Biopharmaceutical Ltd.  | 4324000 | 4141100 |
| WH Group Ltd.  | 1677000 | 1678908 |
|  |  | **14561687** |
| **Israel 0.1%** | **Israel 0.1%** | **Israel 0.1%** |
| Check Point Software Technologies Ltd. \* | 2200 | **409640** |
| **Italy 2.6%** | **Italy 2.6%** | **Italy 2.6%** |
| Enel SpA  | 754675 | 6654939 |
| Poste Italiane SpA  | 42461 | 917366 |
| UniCredit SpA  | 157760 | 11606997 |
|  |  | **19179302** |
| **Japan 18.9%** | **Japan 18.9%** | **Japan 18.9%** |
| Asics Corp.  | 253700 | 5964306 |
| Central Japan Railway Co.  | 299000 | 6970341 |
| Daifuku Co. Ltd.  | 75500 | 1911373 |
| Daiwa House Industry Co. Ltd.  | 170000 | 5620355 |

---

**13**

------

Schwab International Core Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Daiwa Securities Group, Inc.  | 578000 | 4023950 |
| Fast Retailing Co. Ltd.  | 9300 | 2836776 |
| Hitachi Ltd.  | 176000 | 5385713 |
| Honda Motor Co. Ltd.  | 236000 | 2443285 |
| Hoya Corp.  | 50403 | 6358978 |
| Hulic Co. Ltd.  | 220800 | 2105925 |
| Japan Airlines Co. Ltd.  | 412800 | 8197170 |
| Japan Post Holdings Co. Ltd.  | 394600 | 3654259 |
| Japan Post Insurance Co. Ltd.  | 91500 | 2342821 |
| Japan Tobacco, Inc.  | 80300 | 2293337 |
| KDDI Corp.  | 247500 | 4061871 |
| Komatsu Ltd.  | 84100 | 2709524 |
| Konami Group Corp.  | 11100 | 1506922 |
| Mitsubishi Corp.  | 134900 | 2660683 |
| Mitsubishi Electric Corp.  | 27000 | 607290 |
| Mitsubishi UFJ Financial Group, Inc.  | 42700 | 588524 |
| Nomura Holdings, Inc.  | 370800 | 2449614 |
| Olympus Corp.  | 84100 | 1004747 |
| Open House Group Co. Ltd.  | 21400 | 946317 |
| Oracle Corp. Japan  | 33300 | 3601209 |
| ORIX Corp.  | 356800 | 8014814 |
| Otsuka Holdings Co. Ltd.  | 138300 | 6584422 |
| Persol Holdings Co. Ltd.  | 1852400 | 3540766 |
| Recruit Holdings Co. Ltd.  | 79200 | 4699025 |
| Sanrio Co. Ltd.  | 62900 | 2580922 |
| SCREEN Holdings Co. Ltd.  | 15000 | 1170149 |
| Shionogi & Co. Ltd.  | 171500 | 2868220 |
| SoftBank Corp.  | 491200 | 709703 |
| Sompo Holdings, Inc.  | 132400 | 3904082 |
| Sony Group Corp.  | 481000 | 11569637 |
| Sumitomo Mitsui Financial Group, Inc.  | 195500 | 4931801 |
| Tokio Marine Holdings, Inc.  | 171500 | 6886221 |
| Tokyo Electron Ltd.  | 24600 | 3910876 |
|  |  | **141615928** |
| **Luxembourg 0.4%** | **Luxembourg 0.4%** | **Luxembourg 0.4%** |
| Spotify Technology SA \* | 4500 | **2819430** |
| **Netherlands 3.9%** | **Netherlands 3.9%** | **Netherlands 3.9%** |
| ABN AMRO Bank NV, GDR  | 380767 | 11007378 |
| ASML Holding NV  | 13050 | 9044601 |
| Koninklijke Ahold Delhaize NV  | 185901 | 7342420 |
| Wolters Kluwer NV  | 12545 | 1953996 |
|  |  | **29348395** |
| **Norway 0.9%** | **Norway 0.9%** | **Norway 0.9%** |
| DNB Bank ASA  | 99173 | 2509051 |
| Kongsberg Gruppen ASA  | 138039 | 4125037 |
|  |  | **6634088** |
| **Republic of Korea 1.9%** | **Republic of Korea 1.9%** | **Republic of Korea 1.9%** |
| Samsung Electronics Co. Ltd.  | 127877 | 6517115 |
| SK Hynix, Inc.  | 40720 | 7892180 |
|  |  | **14409295** |
| **Singapore 0.8%** | **Singapore 0.8%** | **Singapore 0.8%** |
| Yangzijiang Shipbuilding Holdings Ltd.  | 3207800 | **6291868** |
| **South Africa 0.6%** | **South Africa 0.6%** | **South Africa 0.6%** |
| Harmony Gold Mining Co. Ltd.  | 327242 | **4381582** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Spain 4.8%** | **Spain 4.8%** | **Spain 4.8%** |
| Aena SME SA  | 432582 | 11648615 |
| Banco Bilbao Vizcaya Argentaria SA  | 382141 | 6373446 |
| Banco Santander SA  | 1078329 | 9263689 |
| Endesa SA  | 63394 | 1833951 |
| &nbsp;&nbsp;&nbsp;&nbsp; International Consolidated Airlines Group <br> SA <br>| 1325145 | 6621206 |
|  |  | **35740907** |
| **Sweden 1.9%** | **Sweden 1.9%** | **Sweden 1.9%** |
| Atlas Copco AB, A Shares  | 423670 | 6451810 |
| Telefonaktiebolaget LM Ericsson, B Shares  | 611488 | 4441592 |
| Volvo AB, B Shares  | 124682 | 3580840 |
|  |  | **14474242** |
| **Switzerland 10.5%** | **Switzerland 10.5%** | **Switzerland 10.5%** |
| ABB Ltd.  | 183387 | 11974821 |
| Amrize Ltd. \* | 82111 | 4150788 |
| Geberit AG  | 4280 | 3278901 |
| Holcim AG \* | 136850 | 10913776 |
| Logitech International SA  | 33212 | 3079644 |
| Nestle SA  | 114343 | 9990956 |
| Novartis AG  | 152840 | 17406496 |
| Roche Holding AG  | 50387 | 15724424 |
| &nbsp;&nbsp;&nbsp;&nbsp; Schindler Holding AG, Participation <br> Certificates <br>| 7141 | 2582442 |
|  |  | **79102248** |
| **Taiwan 2.0%** | **Taiwan 2.0%** | **Taiwan 2.0%** |
| MediaTek, Inc.  | 91000 | 4120896 |
| &nbsp;&nbsp;&nbsp;&nbsp; Taiwan Semiconductor Manufacturing Co. <br> Ltd. <br>| 274000 | 10548795 |
|  |  | **14669691** |
| **United Kingdom 15.6%** | **United Kingdom 15.6%** | **United Kingdom 15.6%** |
| AstraZeneca PLC  | 86621 | 12637279 |
| BAE Systems PLC  | 69024 | 1646955 |
| Barclays PLC  | 996505 | 4870934 |
| Fresnillo PLC  | 106775 | 1968790 |
| Games Workshop Group PLC  | 39803 | 8528276 |
| GSK PLC  | 416253 | 7656550 |
| HSBC Holdings PLC  | 1266263 | 15426845 |
| IMI PLC  | 127553 | 3726452 |
| Imperial Brands PLC  | 240572 | 9377348 |
| NatWest Group PLC  | 1325619 | 9201885 |
| Rightmove PLC  | 603787 | 6515760 |
| Rolls-Royce Holdings PLC  | 1180255 | 16751325 |
| Shell PLC  | 412231 | 14812739 |
| Unilever PLC  | 66339 | 3849018 |
|  |  | **116970156** |
| **Total Common Stocks**<br> **(Cost $584,400,434)** | **Total Common Stocks**<br> **(Cost $584,400,434)** | **744291863** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**14**

------

Schwab International Core Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **SHORT-TERM INVESTMENTS** 0.8% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.8% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.8% OF NET ASSETS |
| **Money Market Funds 0.8%** | **Money Market Funds 0.8%** | **Money Market Funds 0.8%** |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional U.S. Government <br> Money Market Fund, Premier Class <br> 4.25% *(a)*<br>| 5923827 | **5923827** |
| **Total Short-Term Investments**<br> **(Cost $5,923,827)** | **Total Short-Term Investments**<br> **(Cost $5,923,827)** | **5923827** |
| **Total Investments in Securities**<br> **(Cost $590,324,261)** | **Total Investments in Securities**<br> **(Cost $590,324,261)** | **750215690** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security. <br> *(a)* The rate shown is the annualized 7-day yield.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

GDR — Global Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of July 31, 2025 (see notes to portfolio holdings for additional information):

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $— | &nbsp;&nbsp;&nbsp; $602812435 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $602812435 |
| &nbsp;&nbsp;&nbsp;&nbsp; Brazil | 3994975 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 3994975 |
| &nbsp;&nbsp;&nbsp;&nbsp; Canada | 11298831 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 11298831 |
| &nbsp;&nbsp;&nbsp;&nbsp; Greece | 5749220 | &nbsp;&nbsp;&nbsp; 2364177 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 8113397 |
| &nbsp;&nbsp;&nbsp;&nbsp; Israel | 409640 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 409640 |
| &nbsp;&nbsp;&nbsp;&nbsp; Luxembourg | 2819430 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 2819430 |
| &nbsp;&nbsp;&nbsp;&nbsp; Spain | 1833951 | &nbsp;&nbsp;&nbsp; 33906956 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 35740907 |
| &nbsp;&nbsp;&nbsp;&nbsp; Switzerland | 4150788 | &nbsp;&nbsp;&nbsp; 74951460 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 79102248 |
| Short-Term Investments<sup>1</sup> <br>| 5923827 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 5923827 |
| **Total** | **$36180662** | &nbsp;&nbsp; **$714035028** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$750215690** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**15**

------

Schwab Active Equity Funds

**Notes to Portfolio Holdings (Unaudited)** 

------

Pursuant to Rule 2a-5 under the Investment Company Act of 1940, as amended (the 1940 Act), the Board of Trustees (the Board) has designated authority to a Valuation Designee, the funds' investment adviser, to make fair valuation determinations under adopted procedures, subject to Board oversight. The investment adviser has formed a Pricing Committee to administer the pricing and valuation of portfolio securities and other assets and liabilities as well as to ensure that prices used for internal purposes or provided by third parties reasonably reflect fair value. The Valuation Designee may utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

Securities held in the funds' portfolio are valued every business day. The following valuation policies and procedures are used by the Valuation Designee to value various types of securities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● **Securities traded on an exchange or over-the-counter:** Traded securities are valued at the closing value for the day, or, on days when no closing value has been reported, at the mean of the most recent bid and ask quotes. Securities that are primarily traded on foreign exchanges are valued at the official closing price or the last sales price on the exchange where the securities are principally traded with these values then translated into U.S. dollars at the current exchange rate, unless these securities are fair valued as discussed below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● **Foreign equity security fair valuation:** The Valuation Designee has adopted procedures to fair value foreign equity securities that are traded in markets that close prior to the valuation of a fund's holdings. By fair valuing securities whose prices may have been affected by events occurring after the close of trading, the Valuation Designee seeks to establish prices that investors might expect to realize upon the current sales of these securities. This methodology is designed to deter "arbitrage" market timers, who seek to exploit delays between the change in the value of a fund's portfolio holdings and the net asset value (NAV) of a fund's shares and seeks to help ensure that the prices at which a fund's shares are purchased and redeemed are fair and do not result in dilution of shareholder interest or other harm to shareholders. When fair value pricing is used at the open or close of a reporting period, it may cause a temporary divergence between the return of a fund and that of its comparative index or benchmark.

&nbsp;&nbsp;&nbsp;&nbsp;● **Futures contracts:** Futures contracts are valued at their settlement prices as of the close of their exchanges.

&nbsp;&nbsp;&nbsp;&nbsp;● **Mutual funds:** Mutual funds are valued at their respective NAVs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● **Securities for which no quoted value is available:** The Valuation Designee has adopted procedures to fair value a fund's securities when market prices are not "readily available" or are unreliable. For example, a security may be fair valued when it's de-listed or its trading is halted or suspended; when a security's primary pricing source is unable or unwilling to provide a price; or when a security's primary trading market is closed during regular market hours. Fair value determinations are made in good faith in accordance with adopted valuation procedures. The Valuation Designee considers a number of factors, including unobservable market inputs, when arriving at fair value. The Valuation Designee may employ methods such as the review of related or comparable assets or liabilities, related market activities, recent transactions, market multiples, book values, transactional back-testing, disposition analysis and other relevant information. Due to the subjective and variable nature of fair value pricing, there can be no assurance that a fund could obtain the fair value assigned to the security upon the sale of such security.

In accordance with the authoritative guidance on fair value measurements and disclosures under generally accepted accounting principles in the United States of America (GAAP), the funds disclose the fair value of their investments in a hierarchy that prioritizes the significant inputs to valuation methods used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). If inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the valuation. If it is determined that either the volume and/or level of activity for an asset or liability has significantly decreased (from normal conditions for that asset or liability) or price quotations or observable inputs are not associated with orderly transactions, increased analysis and the Valuation Designee's judgment will be required to estimate fair value.

The three levels of the fair value hierarchy are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Level 1 — quoted prices in active markets for identical investments — Investments whose values are based on quoted market prices in active markets. These generally include active listed equities, mutual funds, exchange-traded funds (ETFs) and futures contracts. Mutual funds and ETFs are classified as Level 1 prices, without consideration to the classification level of the underlying securities held which could be Level 1, Level 2 or Level 3 in the fair value hierarchy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Level 2 — other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) — Investments that trade in markets that are not considered to be active, but whose values are based on quoted market prices, dealer quotations or valuations provided by alternative pricing sources supported by observable inputs are classified as Level 2 prices. These generally include forward foreign currency exchange contracts, U.S. government and sovereign obligations, most government agency securities, investment-grade corporate bonds, certain mortgage products, less liquid listed equities, and state, municipal and provincial obligations. In addition, international securities whose markets close

**16**

------

Schwab Active Equity Funds

**Notes to Portfolio Holdings (Unaudited) (continued)**

------

hours before the valuation of a fund's holdings may require fair valuations due to significant movement in the U.S. markets occurring after the daily close of foreign markets. The Valuation Designee has approved a vendor that calculates fair valuations of international equity securities based on a number of factors that appear to correlate to the movements in the U.S. markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Level 3 — significant unobservable inputs (including the Valuation Designee's assumptions in determining the fair value of investments) — Investments whose values are classified as Level 3 prices have significant unobservable inputs, as they may trade infrequently or not at all. When observable prices are not readily available for these securities, one or more valuation methods are used for which sufficient and reliable data is available. The inputs used in estimating the value of Level 3 prices may include the original transaction price, quoted prices for similar securities or assets in active markets, completed or pending third-party transactions in the underlying investment or comparable issuers, and changes in financial ratios or cash flows. Level 3 prices may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated in the absence of market information. Assumptions used due to the lack of observable inputs may significantly impact the resulting fair value and therefore a fund's results of operations.

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

REG87636JUL25

**17**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** SCHWAB CAPITAL TRUST

- **b. Investment Company Act file number:** 811-07704

- **c. CIK number of Registrant:** 0000904333

- **d. LEI of Registrant:** 549300PEK1H7N1HLC797

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 211 MAIN STREET

  - **City:** SAN FRANCISCO

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-648-5300

**Item A.2. Information about the Series.**

- **a. Name of Series:** Schwab Health Care Fund

- **b. EDGAR series identifier (if any):** S000005519

- **c. LEI of Series:** 5493000OCKQ3NPNPGA79

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-10-31

- **b. Date as of which information is reported:** 2025-07-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $612902670.59

**Total Liabilities:** $482785.08

**Net Assets:** $612419885.51

**Cash Not Reported:** $643990.36

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000015021 | -5.04%               | 1.70%                | -2.57%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $73170.41                | $-35194486.40                              |
| Month 2  | $774926.64               | $9581424.74                                |
| Month 3  | $-2770344.86             | $-13531430.20                              |

### Schedule of Portfolio Investments

| Name                                               | Title                                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Swedish Orphan Biovitrum AB                        | Swedish Orphan Biovitrum AB                        | CUSIP: 000000000<br>LEI: 549300124Y3MQI87PT35 | Long             | EC               | CORP              | SE        |     60116 | NS      | $1652978.83   | 0.27%             |  |  |  | No            |                  2 | On Loan: No      |
| Vertex Pharmaceuticals Inc                         | Vertex Pharmaceuticals Inc                         | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     29206 | NS      | $13343345.22  | 2.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                                  | Johnson & Johnson                                  | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    206798 | NS      | $34067902.52  | 5.56%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                             | UnitedHealth Group Inc                             | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     89803 | NS      | $22411236.68  | 3.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc                   | Prestige Consumer Healthcare Inc                   | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     77273 | NS      | $5714338.35   | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals Inc                       | Catalyst Pharmaceuticals Inc                       | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |    176923 | NS      | $3773767.59   | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                         | AbbVie Inc                                         | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    176334 | NS      | $33330652.68  | 5.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                       | Thermo Fisher Scientific Inc                       | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     54777 | NS      | $25618107.36  | 4.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Consun Pharmaceutical Group Ltd                    | Consun Pharmaceutical Group Ltd                    | CUSIP: 000000000<br>LEI: 300300LQFLNDZZHCNN43 | Long             | EC               | CORP              | KY        |    730000 | NS      | $1280429.58   | 0.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Agilent Technologies Inc                           | Agilent Technologies Inc                           | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |      5272 | NS      | $605278.32    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems Inc                          | Merit Medical Systems Inc                          | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |     26699 | NS      | $2265677.14   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| DaVita Inc                                         | DaVita Inc                                         | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     20282 | NS      | $2846984.34   | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| As One Corp                                        | As One Corp                                        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     30000 | NS      | $471442.43    | 0.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Medtronic PLC                                      | Medtronic PLC                                      | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    247047 | NS      | $22293521.28  | 3.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Santen Pharmaceutical Co Ltd                       | Santen Pharmaceutical Co Ltd                       | CUSIP: 000000000<br>LEI: 529900TPT3I7C17MIM03 | Long             | EC               | CORP              | JP        |    325000 | NS      | $3590896.61   | 0.59%             |  |  |  | No            |                  2 | On Loan: No      |
| Roche Holding AG                                   | Roche Holding AG                                   | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     35909 | NS      | $11206230.36  | 1.83%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                                         | Zoetis Inc                                         | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |     19828 | NS      | $2890724.12   | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                             | Boston Scientific Corp                             | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    148876 | NS      | $15620069.92  | 2.55%             |  |  |  | No            |                  1 | On Loan: No      |
| ResMed Inc                                         | ResMed Inc                                         | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |      4991 | NS      | $1357252.54   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                                   | Novo Nordisk A/S                                   | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    195625 | NS      | $9098120.89   | 1.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Daiichi Sankyo Co Ltd                              | Daiichi Sankyo Co Ltd                              | CUSIP: 000000000<br>LEI: 353800XGIU2IHQGC9504 | Long             | EC               | CORP              | JP        |    167000 | NS      | $4096830.62   | 0.67%             |  |  |  | No            |                  2 | On Loan: No      |
| United Therapeutics Corp                           | United Therapeutics Corp                           | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     21885 | NS      | $6011809.50   | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson & Co                              | Becton Dickinson & Co                              | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |     38551 | NS      | $6871715.75   | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| United Laboratories International Holdings Ltd/The | United Laboratories International Holdings Ltd/The | CUSIP: 000000000<br>LEI: 2549007JL3XIH77JXN70 | Long             | EC               | CORP              | KY        |   1424000 | NS      | $2669362.19   | 0.44%             |  |  |  | No            |                  2 | On Loan: No      |
| ANI Pharmaceuticals Inc                            | ANI Pharmaceuticals Inc                            | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     91556 | NS      | $5800072.60   | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                                 | IQVIA Holdings Inc                                 | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     50629 | NS      | $9409905.94   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                       | Stryker Corp                                       | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     65457 | NS      | $25706927.61  | 4.20%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                                            | GSK PLC                                            | CUSIP: 000000000<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |    362548 | NS      | $6668701.22   | 1.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Cigna Group/The                                    | Cigna Group/The                                    | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |     40788 | NS      | $10905895.44  | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                                    | CVS Health Corp                                    | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |     42519 | NS      | $2640429.90   | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Eckert & Ziegler SE                                | Eckert & Ziegler SE                                | CUSIP: 000000000<br>LEI: 391200EUDABLUKXCKG48 | Long             | EC               | CORP              | DE        |      4081 | NS      | $310454.30    | 0.05%             |  |  |  | No            |                  2 | On Loan: No      |
| Samsung Biologics Co Ltd                           | Samsung Biologics Co Ltd                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |      1720 | NS      | $1314127.39   | 0.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Incyte Corp                                        | Incyte Corp                                        | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     14800 | NS      | $1108372.00   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Hugel Inc                                          | Hugel Inc                                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |     12409 | NS      | $2995269.55   | 0.49%             |  |  |  | No            |                  2 | On Loan: No      |
| ADMA Biologics Inc                                 | ADMA Biologics Inc                                 | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    225013 | NS      | $4207743.10   | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                    | AstraZeneca PLC                                    | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     73703 | NS      | $10752651.11  | 1.76%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc                             | Intuitive Surgical Inc                             | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |      7152 | NS      | $3440755.68   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                          | Amgen Inc                                          | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     74500 | NS      | $21984950.00  | 3.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Kissei Pharmaceutical Co Ltd                       | Kissei Pharmaceutical Co Ltd                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     15000 | NS      | $441924.41    | 0.07%             |  |  |  | No            |                  2 | On Loan: No      |
| Fisher & Paykel Healthcare Corp Ltd                | Fisher & Paykel Healthcare Corp Ltd                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | NZ        |     28477 | NS      | $617349.35    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Classys Inc                                        | Classys Inc                                        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |     73910 | NS      | $3058082.72   | 0.50%             |  |  |  | No            |                  2 | On Loan: No      |
| Veracyte Inc                                       | Veracyte Inc                                       | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |     99661 | NS      | $2343030.11   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                                | Abbott Laboratories                                | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    155023 | NS      | $19562352.37  | 3.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                                       | Innoviva Inc                                       | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |     37476 | NS      | $680938.92    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc                     | GE HealthCare Technologies Inc                     | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |     64608 | NS      | $4607842.56   | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Envista Holdings Corp                              | Envista Holdings Corp                              | CUSIP: 29415F104<br>LEI: 549300BX623VURJZ5269 | Long             | EC               | CORP              | US        |     67600 | NS      | $1276964.00   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Ipsen SA                                           | Ipsen SA                                           | CUSIP: 000000000<br>LEI: 549300M6SGDPB4Z94P11 | Long             | EC               | CORP              | FR        |     21090 | NS      | $2485078.82   | 0.41%             |  |  |  | No            |                  2 | On Loan: No      |
| Pfizer Inc                                         | Pfizer Inc                                         | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    237075 | NS      | $5521476.75   | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp                                          | Hoya Corp                                          | CUSIP: 000000000<br>LEI: 353800X4VR3BHEUCJB42 | Long             | EC               | CORP              | JP        |     88700 | NS      | $11190629.91  | 1.83%             |  |  |  | No            |                  2 | On Loan: No      |
| Bio-Techne Corp                                    | Bio-Techne Corp                                    | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     35888 | NS      | $1964150.24   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                             | UCB SA                                             | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |      9560 | NS      | $2054012.22   | 0.34%             |  |  |  | No            |                  2 | On Loan: No      |
| Livzon Pharmaceutical Group Inc                    | Livzon Pharmaceutical Group Inc                    | CUSIP: 000000000<br>LEI: 529900Y4GWTVVTORJ443 | Long             | EC               | CORP              | CN        |     12300 | NS      | $58876.36     | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| QIAGEN NV                                          | QIAGEN NV                                          | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |     61243 | NS      | $3021729.62   | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMerieux                                         | BioMerieux                                         | CUSIP: 000000000<br>LEI: 549300AK8Y0LBIQ4T071 | Long             | EC               | CORP              | FR        |     12745 | NS      | $1823608.82   | 0.30%             |  |  |  | No            |                  2 | On Loan: No      |
| Cardinal Health Inc                                | Cardinal Health Inc                                | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |     18910 | NS      | $2935210.20   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                        | Cencora Inc                                        | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     33083 | NS      | $9464384.64   | 1.55%             |  |  |  | No            |                  1 | On Loan: No      |
| 3SBio Inc                                          | 3SBio Inc                                          | CUSIP: 000000000<br>LEI: 529900P0TQC1E9Y7FN31 | Long             | EC               | CORP              | KY        |     90000 | NS      | $363840.65    | 0.06%             |  |  |  | No            |                  2 | On Loan: No      |
| Galenica AG                                        | Galenica AG                                        | CUSIP: 000000000<br>LEI: 506700W4772BD8016Z20 | Long             | EC               | CORP              | CH        |      7332 | NS      | $778142.38    | 0.13%             |  |  |  | No            |                  2 | On Loan: No      |
| Natera Inc                                         | Natera Inc                                         | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11800 | NS      | $1577188.00   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                                       | Exelixis Inc                                       | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    191686 | NS      | $6942866.92   | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| EssilorLuxottica SA                                | EssilorLuxottica SA                                | CUSIP: 000000000<br>LEI: 549300M3VH1A3ER1TB49 | Long             | EC               | CORP              | FR        |     25358 | NS      | $7540311.62   | 1.23%             |  |  |  | No            |                  2 | On Loan: No      |
| HealthEquity Inc                                   | HealthEquity Inc                                   | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |     41561 | NS      | $4031417.00   | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Ambea AB                                           | Ambea AB                                           | CUSIP: 000000000<br>LEI: 549300AEVNZRHYI5HV24 | Long             | EC               | CORP              | SE        |     45000 | NS      | $566123.12    | 0.09%             |  |  |  | No            |                  2 | On Loan: No      |
| HCA Healthcare Inc                                 | HCA Healthcare Inc                                 | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |      6463 | NS      | $2287837.37   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp                                      | McKesson Corp                                      | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     14760 | NS      | $10236650.40  | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Pro Medicus Ltd                                    | Pro Medicus Ltd                                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | AU        |     11721 | NS      | $2406960.95   | 0.39%             |  |  |  | No            |                  2 | On Loan: No      |
| Danaher Corp                                       | Danaher Corp                                       | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |     19100 | NS      | $3765756.00   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Integer Holdings Corp                              | Integer Holdings Corp                              | CUSIP: 45826H109<br>LEI: 549300SUD2ED5XG6X569 | Long             | EC               | CORP              | US        |      8800 | NS      | $954888.00    | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd                                  | Shionogi & Co Ltd                                  | CUSIP: 000000000<br>LEI: 35380049VXDTHZI3DY35 | Long             | EC               | CORP              | JP        |     74000 | NS      | $1237599.39   | 0.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Demant A/S                                         | Demant A/S                                         | CUSIP: 000000000<br>LEI: 213800RM6L9LN78BVA56 | Long             | EC               | CORP              | DK        |     15150 | NS      | $573997.02    | 0.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Hansoh Pharmaceutical Group Co Ltd                 | Hansoh Pharmaceutical Group Co Ltd                 | CUSIP: 000000000<br>LEI: 254900Q6MR00EBXTPF42 | Long             | EC               | CORP              | KY        |    710000 | NS      | $3189795.47   | 0.52%             |  |  |  | No            |                  2 | On Loan: No      |
| Novartis AG                                        | Novartis AG                                        | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |    186482 | NS      | $21237883.85  | 3.47%             |  |  |  | No            |                  2 | On Loan: No      |
| Mettler-Toledo International Inc                   | Mettler-Toledo International Inc                   | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      9281 | NS      | $11449784.08  | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Encompass Health Corp                              | Encompass Health Corp                              | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |     40593 | NS      | $4469695.23   | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Alfresa Holdings Corp                              | Alfresa Holdings Corp                              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     34100 | NS      | $494995.35    | 0.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Merck & Co Inc                                     | Merck & Co Inc                                     | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    202766 | NS      | $15840079.92  | 2.59%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PLC                                         | STERIS PLC                                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     27020 | NS      | $6119759.80   | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Niagen Bioscience Inc                              | Niagen Bioscience Inc                              | CUSIP: 171077407<br>LEI: 529900OPI7B8JPXCVS70 | Long             | EC               | CORP              | US        |     32598 | NS      | $304791.30    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                        | Waters Corp                                        | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |      7429 | NS      | $2145198.04   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                     | Eli Lilly & Co                                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     85532 | NS      | $63299667.24  | 10.34%            |  |  |  | No            |                  1 | On Loan: No      |
| Recordati Industria Chimica e Farmaceutica SpA     | Recordati Industria Chimica e Farmaceutica SpA     | CUSIP: 000000000<br>LEI: 815600FBF92FD3531704 | Long             | EC               | CORP              | IT        |     35927 | NS      | $2060545.72   | 0.34%             |  |  |  | No            |                  2 | On Loan: No      |
| Bristol-Myers Squibb Co                            | Bristol-Myers Squibb Co                            | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     85750 | NS      | $3713832.50   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                                | Gilead Sciences Inc                                | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    171207 | NS      | $19224834.03  | 3.14%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-08-25

**Name of Applicant:** SCHWAB CAPITAL TRUST

**Signature:** Dana Smith

**Name of Signer:** Dana Smith

**Title:** CFO